Our identification of RPLP1 and RPL27 as robust RGs in this panel of hypoxic Luminal A and TNBC cell lines provides a valuable resource for future studies investigating important transcriptional changes occurring during breast cancer progression. Here, RPL27 is linked to breast carcinoma.